| 2 Dec 2025 | 07:00:02 | Cancellation - Belluscura plc |
| 5 Nov 2025 | 09:47:08 | Intention to appoint Administrator Update |
| 31 Oct 2025 | 12:15:00 | Intention to appoint Administrator |
| 30 Oct 2025 | 11:30:00 | Replacement Statement re US Subsidiary Update |
| 30 Oct 2025 | 10:38:14 | Statement re US Subsidiary Chapter 7 Update |
| 7 Jul 2024 | Annual Report and Accounts (to 2023-12-31) | |
| 15 Jul 2023 | Annual Report and Accounts (to 2022-12-31) | |
| 12 Apr 2022 | Annual Report and Accounts (to 2021-12-31) |
Belluscura is a British medical device company that aims to enhance the lives of millions of individuals globally through its patented oxygen enrichment technology.
| 2 Dec 2025 | 07:00:02 | Cancellation - Belluscura plc |
| 5 Nov 2025 | 09:47:08 | Intention to appoint Administrator Update |
| 31 Oct 2025 | 12:15:00 | Intention to appoint Administrator |
| 30 Oct 2025 | 11:30:00 | Replacement Statement re US Subsidiary Update |
| 30 Oct 2025 | 10:38:14 | Statement re US Subsidiary Chapter 7 Update |
| 7 Jul 2024 | Annual Report and Accounts (to 2023-12-31) | |
| 15 Jul 2023 | Annual Report and Accounts (to 2022-12-31) | |
| 12 Apr 2022 | Annual Report and Accounts (to 2021-12-31) |
Belluscura is a British medical device company that aims to enhance the lives of millions of individuals globally through its patented oxygen enrichment technology.
